110 related articles for article (PubMed ID: 9870439)
1. Which level of cytokine production is critical in haemodialysis?
Cappelli G; DiFelice A; Perrone S; Ballestri M; Bonucchi D; Savazzi AM; Ciuffreda A; Lusvarghi E
Nephrol Dial Transplant; 1998; 13 Suppl 7():55-60. PubMed ID: 9870439
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 and interleukin-1 receptor antagonist production during haemodialysis: which cytokine is a surrogate marker for dialysis-related complications?
Dinarello CA
Nephrol Dial Transplant; 1995; 10 Suppl 3():25-8. PubMed ID: 7494610
[TBL] [Abstract][Full Text] [Related]
3. Cytokine production in haemodiafiltration: a multicentre study.
Panichi V; De Pietro S; Andreini B; Migliori M; Tessore V; Taccola D; Rindi P; Palla R; Tetta C
Nephrol Dial Transplant; 1998 Jul; 13(7):1737-44. PubMed ID: 9681721
[TBL] [Abstract][Full Text] [Related]
4. Influence of first and long-term dialysis on uraemia-associated increased basal production of interleukin-1 and tumour necrosis factor alpha by circulating monocytes.
Herbelin A; Ureña P; Nguyen AT; Zingraff J; Descamps-Latscha B
Nephrol Dial Transplant; 1991; 6(5):349-57. PubMed ID: 1870752
[TBL] [Abstract][Full Text] [Related]
5. Cytokine production by monocytes during haemodialysis.
Schaefer RM; Paczek L; Heidland A
Nephrol Dial Transplant; 1991; 6 Suppl 2():14-7. PubMed ID: 1866062
[TBL] [Abstract][Full Text] [Related]
6. Haemodialysis membranes modulate chronically the production of TNF alpha, IL1 beta and IL6.
Mege JL; Olmer M; Purgus R; Bertocchio P; Farnarier C; Kaplanski S; Capo C; Bongrand P
Nephrol Dial Transplant; 1991; 6(11):868-75. PubMed ID: 1775252
[TBL] [Abstract][Full Text] [Related]
7. Impact of contaminated dialysate on long-term haemodialysis-related complications: is it really that important?
Nubé MJ; Grooteman MP
Nephrol Dial Transplant; 2001 Oct; 16(10):1986-91. PubMed ID: 11572884
[No Abstract] [Full Text] [Related]
8. Involvement of peripheral blood monocytes in haemodialysis: in vivo induction of tumour necrosis factor alpha, interleukin 6 and beta 2-microglobulin.
Pertosa G; Marfella C; Tarantino EA; Di Cillo M; Manno C; Russo R; Schena FP
Nephrol Dial Transplant; 1991; 6 Suppl 2():18-23. PubMed ID: 1866063
[TBL] [Abstract][Full Text] [Related]
9. Permeability of cellulosic and non-cellulosic membranes to endotoxin subunits and cytokine production during in-vitro haemodialysis.
Ureña P; Herbelin A; Zingraff J; Lair M; Man NK; Descamps-Latscha B; Drüeke T
Nephrol Dial Transplant; 1992; 7(1):16-28. PubMed ID: 1316577
[TBL] [Abstract][Full Text] [Related]
10. Cytokine production in haemodialysis.
Memoli B
Blood Purif; 1999; 17(2-3):149-58. PubMed ID: 10449873
[TBL] [Abstract][Full Text] [Related]
11. [Dialysate and biocompatibility in hemodialysis].
Berland Y
Nephrologie; 1998; 19(6):329-34. PubMed ID: 9836194
[TBL] [Abstract][Full Text] [Related]
12. Cytokine production during hemodialysis: effects of dialytic membrane and complement activation.
Lin YF; Chang DM; Shaio MF; Lu KC; Chyr SH; Li BL; Sheih SD
Am J Nephrol; 1996; 16(4):293-9. PubMed ID: 8739281
[TBL] [Abstract][Full Text] [Related]
13. When good water goes bad: how it happens, clinical consequences and possible solutions.
Lonnemann G
Blood Purif; 2004; 22(1):124-9. PubMed ID: 14732820
[TBL] [Abstract][Full Text] [Related]
14. Do cytokine-inducing substances penetrate through dialysis membranes and stimulate monocytes?
Kumano K; Yokota S; Nanbu M; Sakai T
Kidney Int Suppl; 1993 Jun; 41():S205-8. PubMed ID: 8320922
[TBL] [Abstract][Full Text] [Related]
15. Endotoxins modulate chronically tumour necrosis factor alpha and interleukin 6 release by uraemic monocytes.
Pertosa G; Gesualdo L; Bottalico D; Schena FP
Nephrol Dial Transplant; 1995; 10(3):328-33. PubMed ID: 7792027
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of lipopolysaccharide-induced interleukin-1 production by human monocytes. Clinical relevance in patients undergoing hemodialysis.
Haeffner-Cavaillon N; Bacle F; Caroff M; Cavaillon JM
Prog Clin Biol Res; 1988; 272():89-101. PubMed ID: 3260673
[No Abstract] [Full Text] [Related]
17. Detection of peptidoglycan and endotoxin in dialysate, using silkworm larvae plasma and limulus amebocyte lysate methods.
Tsuchida K; Takemoto Y; Yamagami S; Edney H; Niwa M; Tsuchiya M; Kishimoto T; Shaldon S
Nephron; 1997; 75(4):438-43. PubMed ID: 9127331
[TBL] [Abstract][Full Text] [Related]
18. Blood components influence cytokine induction by bacterial substances.
Schindler R; Eichert F; Lepenies J; Frei U
Blood Purif; 2001; 19(4):380-7. PubMed ID: 11574734
[TBL] [Abstract][Full Text] [Related]
19. Monocyte phenotype and interleukin-1 production in patients undergoing haemodialysis.
Schiller B; Ziegler-Heitbrock HW; Meyer N; Schmidt B; Blumenstein M
Nephron; 1991; 59(4):573-9. PubMed ID: 1837335
[TBL] [Abstract][Full Text] [Related]
20. High-calcium dialysate: a factor associated with inflammation, malnutrition and mortality in non-diabetic maintenance haemodialysis patients.
Hsu CW; Lin JL; Lin-Tan DT; Yen TH; Chen KH; Huang WH; Ho TC; Huang YL
Nephrology (Carlton); 2010 Apr; 15(3):313-20. PubMed ID: 20470300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
